Pharmaceutical company Pharmaxis today announced it had submitted a New Drug Application with the U.S. FDA for Aridol, a bronchial challenge test. Bronchial challenge tests are designed to help in the correct diagnosis and assessment of asthma.
The details can be read here.
No comments:
Post a Comment